LEO PHARMA INC Recall: Taclonex (calcipotriene and betamethasone dipropionate) Topical Sus
LEO PHARMA INC Recall: Taclonex (calcipotriene and betamethasone dipropionate) Topical Sus is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: LEO PHARMA INC; Product: Taclonex (calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064%, packaged in (a) 60 g (NDC 50222
| Recalling firm | LEO PHARMA INC |
|---|---|
| Product | Taclonex (calcipotriene and betamethasone dipropionate) Topical Suspension, 0.005%/0.064%, packaged in (a) 60 g (NDC 50222-501-06), and (b)120 g (50222-501-66) tubes, Rx Only, Manufactured by: LEO Laboratories Ltd., 285 Cashel Road, Dublin 12 Ireland, Distributed by: LEO Pharma Inc. 1 Sylvan Way, Parsippany, NJ 07054. |
| Reason for recall | Labeling: Incorrect or missing package insert: the affected product was packaged with an out-of-date package insert (PI) dated February 2014. |
| Classification | Class III (least serious — unlikely to cause adverse health consequences) |
| Status | Terminated |
| Distribution | Nationwide within US |
| Recall initiated | 20170116 |
| Recall number | D-0477-2017 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →